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The  nitrogen-containing  bisphosphonates  used  for management  of the  patients  with  osteoporosis  were
reported  to inﬂuence  the  function  of renal  tubular  cells.  However,  how  nitrogen-containing  bispho-
sphates  exert  any  effects  on  ion  currents  remains  controversial.  The  effects  of  ibandronate  (Iban),  a
nitrogen-containing  bisphosphonate,  on  ionic  channels,  including  two  types  of  Ca2+-activated  K+ (KCa)
channels,  namely,  large-conductance  KCa (BKCa) and  intermediate-conductance  KCa (IKCa)  channels,  were
investigated  in  Madin–Darby  canine  kidney  (MDCK)  cells.  In whole-cell  current  recordings,  Iban  sup-
pressed  the  amplitude  of  voltage-gated  K+ current  elicited  by  long  ramp  pulse.  Addition  of  Iban  caused  a
reduction  of  BKCa channels  accompanied  by a right  shift  in  the  activation  curve  of  BKCa channels,  despite
no  change  in  single-channel  conductance.  Ca2+ sensitivity  of these  channels  was  modiﬁed  in the  presence
of this  compound;  however,  the  magnitude  of Iban-mediated  decrease  in  BKCa-channel  activity  under
membrane  stretch  with  different  negative  pressure  remained  unchanged.  Iban  suppressed  the  probabil-
ity of  BKCa-channel  openings  linked  primarily  to a  shortening  in  the slow  component  of mean  open  time
in  these  channels.  The  dissociation  constant  needed  for Iban-mediated  suppression  of  mean  open  time
in  MDCK  cells  was  12.2  M.  Additionally,  cell  exposure  to Iban  suppressed  the  activity  of  IKCa channels,
and  DC-EBIO  or  9-phenanthrol  effectively  reversed  its  suppression.  Under  current-clamp  conﬁguration,
Iban  depolarized  the  cells  and  DC-EBIO  or PF573228  reversed  its  depolarizing  effect.  Taken  together,  the
inhibitory  action  of  Iban  on KCa-channel  activity  may  contribute  to  the underlying  mechanism  of  phar-
macological  or  toxicological  actions  of Iban and  its  structurally  similar  bisphosphonates  on  renal  tubular
cells  occurring  in  vivo.
©  2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the CCAbbreviations: BKCa channel, large-conductance Ca2+-activated
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ichloro-1-ethyl-1,3-dihydro-2H-benzimidazol-2-one; DMEM, Dulbecco’s
odiﬁed Eagle’s medium; FBS, fetal bovine serum; H2S, hydrogen sul-
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1. Introduction
Bisphosphonates are recognized as stable analogs of pyrophos-
phates, which have been approved for treatment of post-
menopausal osteoporosis [23]. These compounds are not metab-
olized in either man  or animal, and consequently, they are
the active, parent compounds. The principal route of their
elimination results from renal excretion [15] and these com-
pounds can accumulate in the kidney during therapy [3,38].
It is important to note that potential nephrotoxicity has
been observed in patients receiving high-dose bisphospho-
nate therapy, particularly when administrated by rapid intra-
venous administration [2,18,22,27–29,32]. The renal effects of
these compounds were thought to be through a mechanism
linked to their inhibition of farnesyl pyrophosphate synthase
[19].
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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It has been demonstrated that intermittent treatment with
bandronate (Iban) or zoledronate, which is known to be a
otent nitrogen-containing bisphosphonate, caused hypertrophy
nd hyperplasia of distal tubules and collecting ducts in the rats
29]. Alternatively, previous observations at our laboratory showed
hat iban was able to decrease the activity of IKCa channels in RAW
64.7 osteoclast precursor cells and that its block of these channels
ppeared to have a causal link to the inhibition of cell migration
45]. In contrast, another noteworthy study by Ma  et al. [20] has
emonstrated that zoledronate could activate the activity of BKCa
hannels in breast cancer cells and that such effect appeared to
e responsible for the apoptotic change caused by this compound.
owever, the ionic mechanism of their actions on renal tubular
ells remains largely elusive.
The BKCa channels (maxi-K, KCa1.1, KCNNMA1,  Slo1) are prod-
cts of a nearly ubiquitous, alternatively spliced gene. They possess
he largest single-channel conductance of all K+ selective channels,
hich are synergistically activated by membrane depolarization
nd/or elevation of [Ca2+]i [43]. These pharmacologically promiscu-
us channels which can be stimulated by a chemically diverse range
f small molecule drugs are functionally expressed in many cell
ypes, including renal tubular cells [5,17,24,37,43,44]. Of impor-
ance, these channels are localized in a variety of kidney cells, where
hey have important roles ranging from regulators of glomeru-
ar ﬁltration to conduits for K+ secretion [17,24,40,41]. However,
ow Iban can interact with these channels to perturb whole-cell
urrents or membrane potential is incompletely understood.
Previous studies have reported the important roles of KCa
hannels in kidney functions. For example, perfusion of isolated
ollecting ducts revealed that iberiotoxin, an inhibitor of BKCa chan-
els, could inhibit K+ secretion during high tubular ﬂuid ﬂow [42].
enal responsiveness to consumption of high K, alkaline diet was
eported to be seriously impaired in BK-4 knockout mice and
heir plasma K+ level was greatly elevated [9,41]. Additionally, IKCa
hannels have been demonstrated to be strongly linked to diabetic
ephropathy [10].
The Madin–Darby canine kidney (MDCK) renal tubular cell line
as been a useful model for studies of functional activities existing
n renal tubular cells [13,14]. Therefore, to ﬁll the knowledge gap,
he goals of this study were (1) to investigate possible effects of
ban on macroscopic and single-channel currents and (2) to deter-
ine how it can interact with ion channels to modify membrane
otential of MDCK cells. Besides its inhibition of farnesyl pyrophos-
hate synthase [19], the effects of Iban on ion channels shown in
his study are obligate mechanisms by which it or its structurally
imilar bisphosphonates can inﬂuence the functional activities of
enal tubular cells, if similar ﬁndings occur in vivo.
. Materials and methods
.1. Drugs and solutions
Ibandronate sodium (Iban; C9H22NO7P2Na · H2O; Bonviva®)
as obtained from Hoffmann-La Roche Ltd. (Basel, Switzerland),
±)-ketamine was from Cerilliant Corp. (Round Rock, TX), paxilline
as from Alomone Labs (Jerusalem, Israel), ionomycin, oxalate
ethanedioate) and sodium hydrosulphide (NaHS) were from
igma–Aldrich Inc. (St. Louis, MO), DC-EBIO (i.e., 5,6-dichloro-1-
thyl-1,3-dihydro-2H-benzimidazol-2-one), and 9-phenanthrol,
F573228 (i.e., 3,4-dihydro-6-[[4-[[[3-(methylsulfonyl)
henyl]methyl]amino]-5(triﬂuoromethyl)-2-pyrimidinyl]amino]-
(1H)-quinolinone) and TRAM-34 (i.e., 1-((2-chloropheny)
diphenyl) methyl)-1H-pyrazole) were from Tocris (Bristol,
K). Chlorotoxin was kindly provided by Dr. Woei-Jer Chuang
Department of Biochemistry, National Cheng Kung Universityrts 2 (2015) 1182–1193 1183
Medical College, Tainan City, Taiwan). All culture media, FBS,
l-glutamine, penicillin-streptomycin, fungizone and trypsin/EDTA
were obtained from Invitrogen (Carlsbad, CA). All other chemicals
were commercially available and of reagent grade. Twice-distilled
water was  de-ionized through a Milli-Q water puriﬁcation system
(APS Water Services Inc., Van Nuys, CA).
The composition of the bathing solution (i.e., normal Tyrode’s
solution) was  136.5 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.53 mM
MgCl2, 5.5 mM glucose, and 5.5 mM HEPES-KOH buffer, pH 7.4. To
measure K+ currents or membrane potential in MDCK cells, the
patch pipette was ﬁlled with a solution consisting of 130 mM K-
aspartate, 20 mM KCl, 1 mM KH2PO4, 1 mM MgCl2, 3 mM Na2ATP,
0.1 mM Na2GTP, 0.1 mM EGTA, and 5 mM HEPES-KOH buffer, pH
7.2.
For the recordings of BKCa-channel activity, high K+-bathing
solution contained 145 mM  KCl, 0.53 mM MgCl2, and 5 mM HEPES-
KOH buffer (pH 7.4), and the pipette solution contained 145 mM
KCl, 2 mM  MgCl2, and 5 mM HEPES-KOH (pH 7.2). The free Ca2+
concentration was  calculated assuming a dissociation constant of
0.1 mM for EGTA and Ca2+ (at pH 7.2) (http://maxchelator.stanford.
edu/CaEGTA-TS.htm).
2.2. Cell preparation
The MDCK cell line (BCRC-60004), a canine renal tubular cell
line, was  obtained from Bioresource Collection and Research Center
(Hsinchu, Taiwan). Cells were routinely cultured in DMEM sup-
plemented with 10% heat-inactivated FBS, 100 U/ml penicillin and
100 g/ml streptomycin at 37 ◦C in 5% CO2-containing humidiﬁed
air [13]. Culture medium was  continuously replaced every 2 days to
maintain a healthy cell population. For long-term storage, the cells
were frozen in DMEM containing 10% dimethyl sulfoxide, and kept
in liquid nitrogen. Prior to their use in electrophysiological exper-
iments, cells were grown on glass coverslips in DMEM,  in order to
have good cell-substrate attachment. Cell viability was commonly
evaluated using a WST-1 cell proliferation assay and an ELISA reader
(Dynatech, Chantilly, VA). A Nikon Eclipse Ti-E inverted microscope
(Li Trading Co., Taipei City, Taiwan) equipped with 5-megapixel
cooled digital camera was  commonly used to observe cell growth.
2.3. Intracellular Ca2+ ([Ca2+]i) measurements of MDCK cells
Cells were loaded with 4 M fura-2/AM (Molecular Probes,
Eugene, OR) for 45 min  at room temperature (20–25 ◦C). Changes
in [Ca2+]i were monitored with single-cell imaging using a Tillvi-
sION imaging system equipped with a Polychrome II high-speed
monochromator (TILL Photonics, Martinsried, Germany). Fura-2
was excited sequentially by 340 and 380 nm light delivered from
a xenon lamp via a ×40, 1.3 NA UV ﬂuor oil objective (Olympus,
Tokyo, Japan). The ﬂuorescent images were collected at 510 nm
scale every 0.5 sec by a Peltier-cooled CCD camera. The ratio of ﬂuo-
rescence, R (340 nm/380 nm), from an individual cell was obtained
by using TILL visION software 4.0 (Till Photonics) [47].
2.4. Electrophysiological measurements
Shortly before the experiments, a coverslip, on which MDCK
cells were grown, was placed on the home-made recording cham-
ber which was mounted on the stage of a CKX-41 inverted
ﬂuorescent microscope (Olympus, Tokyo, Japan) coupled to digi-
tal video system (DCR-TRV30; Sony, Japan) with a magniﬁcation
of up to 1500×. The examined cells were immersed at room tem-
perature (20–25 ◦C) in normal Tyrode’s solution. The electrodes
used were pulled from Kimax-51 capillaries (#34500; Kimble Glass,
Vineland, NJ) in either a PP-83 puller (Narishige, Tokyo, Japan) or
a P-97 Flaming/Brown micropipette puller (Sutter, Novato, CA),
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nd their tips were ﬁre-polished with an MF-83 microforge (Nar-
shige). The pulled electrodes, which commonly had a tip resistance
f 3–5 M when ﬁlled with different internal solutions described
bove, were maneuvered using a WR-98 micromanipulator (Nar-
shige). An anti-vibration air table was used to enhance stability
uring electrophysiological experiments. Patch clamp recordings
ere obtained in cell-attached, inside-out or whole-cell conﬁgura-
ion using an RK-400 (Bio-Logic, Claix, France) or Axopatch 200B
Molecular Devices, Sunnyvale, CA) ampliﬁer [45]. The junctional
otentials between the pipette solution and extracellular medium
ere corrected immediately before seal formation was  made.
To induce membrane stretch, membrane tension of MDCK cells
as altered by applying negative pressure with a calibrated syringe
o the back end of the recording electrode through the suction
ort of the electrode holder [5]. Negative pressure was  monitored
ith a pressure manometer (PM01R; World Precision Instruments,
arasota, FL).
.5. Data recordings and analyses
Data acquisition and analyses were controlled by pCLAMP 10.2
Molecular Devices). Current signals were low-pass ﬁltered at 1 or
 kHz. The data were sampled online in an ASUSPRO-BU401LG lap-
op computer (ASUS, Taipei City, Taiwan) at 10 kHz. With the aid of a
igital-to-analog conversion, the voltage proﬁles with either rect-
ngular or ramp pulses created from pCLAMP 10.2 were utilized
o correctly determine current–voltage (I–V) relationships for ion
urrents (e.g., IK). The digital data achieved during the experiments
ere appropriately analyzed by various analytical tools, including
rigin 8.0 (OriginLab, Northampton, MA), LabChart 7.0 (PowerLab
oftware; AD Instruments, KYS Technology Co., Ltd., New Taipei
ity, Taiwan), and custom-made macros built in an Excel 2013
preadsheet run on Windows 8 (Microsoft, Redmond, WA).
.6. Single-channel analyses
The amplitudes of single BKCa- or IKCa-channel currents seen
n MDCK cells were analyzed by use of pCLAMP 10.2 (Molecular
evices). Multi-gaussian adjustments of the amplitude distribu-
ions among channels were commonly created to ensure the
xistence of single-channel events. The functional independence
mong channels was veriﬁed by comparing the observed sta-
ionary probability with the values calculated according to the
tted Gaussian function embedded in pCLAMP 10.2. The channel
pen probabilities were determined using an iterative process to
inimize the x2 values which were calculated as there were an
dequately large number of independent observations. Open and
losed-time histograms of BKCa channels obtained with or with-
ut addition of different Iban concentrations were determined by
wo-exponential function (i.e., fast and slow components). The
ingle-channel conductance of BKCa or IKCa channels was  calcu-
ated by a linear regression using mean single-channel amplitudes
iven at different levels of voltage.
The effect of Iban on the probability of BKCa-channel openings
een in MDCK cells are explained by a state-dependent blocker,
ecause this compound preferentially binds to the open state of
he channel according to minimal kinetic scheme:
˛
ˇ
OK+1×[B]
k−1
O × Bhere  ˛ and  ˇ are the rate constants for the opening and clos-
ng of BKCa channels, k+1 and k−1 are the forward (blocking) and
ackward (unblocking) rate constants caused by the presence of
ban, and [B] is the Iban concentration. C, O and O × B shown inorts 2 (2015) 1182–1193
the scheme indicates the closed (resting), open, and open-blocked
states, respectively.
On the basis of this reaction scheme, the blocking and unblock-
ing rate constants, k+1 and k−1, were determined from the slow
component in the open time of BKCa channels measured at the
level of +50 mV. Blocking and unblocking rate constants were then
determined using the relation:
1
b
= k+1 × [B] + k−1
where k+1 and k−1 are respectively derived from the slope and the
y-axis intercept at [B] = 0 of the linear regression interpolating the
reciprocal time constant (1/b) versus different Iban concentrations.
According to this relation, the linearized plot of 1/b against [B] (i.e.,
the Iban concentration) was  obtained (Fig. 3A) and the dissociation
constant (KD = k−1/k+1) of Iban can be thereafter generated.
To assess effects of Iban on the activation curve of BKCa channels,
the channel opening probabilities at the different levels of holding
potential were measured. The relationships between the mem-
brane potential and the relative open probability obtained before
and after addition of Iban (10 M)  were ﬁtted with a Boltzmann
function of the following form:
(N × P)
(N × P)max
= 1
1 + exp
[−(V−V1/2)qF
RT
]
where (N × P)max measured at the level of +90 mV in the control was
the taken to be 1.0, V1/2 is the voltage at which there is half-maximal
activation, q the apparent gating charge, F Faraday’s constant, R the
universal gas constant, and T the absolute temperature.
2.7. Statistical analyses
Linear or nonlinear curve-ﬁtting to experimental data in this
study was  carried out by means of either pCLAMP 10.2, Microsoft
Excel 2013 or Origin 8.0 (OriginLab Corp.). The data of macro-
scopic or single-channel currents were presented as the mean
values ± standard error of the mean (SEM) with sample sizes (n)
representing the cell number from which the data were taken.
The paired or unpaired Student’s t-test were initially used for the
statistical analyses. Assuming that statistical difference among dif-
ferent groups is necessarily evaluated, post-hoc Duncan multiple
comparisons were further implemented. Statistical analyses were
performed using the Statistical Package for Social Science 20 (SPSS;
IBM Corp., Armonk, New York). A P value of less than 0.05 was
considered to indicate statistical difference.
3. Results
3.1. Inhibitory effect of Iban on voltage-gated K+ current (IK)
recorded from MDCK cells
In an initial set of electrophysiological experiments, we  evalu-
ated the effect of Iban on IK in these cells under whole-cell current
recordings. As MDCK cells grown on a coverslip were immersed
in normal Tyrode’s solution containing 1.8 mM CaCl2, the IK in
response to a 1 s ramp pulse from −100 to +60 mV  could be readily
elicited at a rate of 0.05 Hz. When cells were exposed to differ-
ent concentrations of Iban, the IK amplitude elicited by the 1 s long
ramp pulse became progressively decreased (Fig. 1). For example, at
the level of +40 mV,  Iban at a concentration of 30 M reduced cur-
rent amplitude by 66.2 ± 2.3% from 785 ± 58 to 265 ± 23 pA (n = 17,
P < 0.05). After washout of Iban, IK amplitude at the same level
returned to 626 ± 34 pA (n = 11). Similar to Iban effects, paxilline
or ketamine effectively suppressed the IK amplitude. Moreover, a
S.-N. Wu et al. / Toxicology Reports 2 (2015) 1182–1193 1185
Fig. 2. Effect of Iban on BKCa-channel activity in MDCK cells. These experiments were conducted as cells were bathed in high-K+ (145 mM)  solution containing 1.8 mM CaCl2.
Cell-attached current recordings were made and each cell was  held at +50 mV.  Followed by standardization with Iban (30 M),  Iban along with NaHS (Iban + NaHS) and
PF573228 (Iban + PF573228) were also monitored for the alteration on BKCa-channel activity which was  measured at the level of +50 mV. (A) Original current traces obtained
with  or without addition of Iban at +50 mV.  control (left, black); 10 M Iban (middle, blue) and 30 M Iban (right, red). (B) Summary of the data showing effects of Iban, Iban
plus  NaHS and Iban plus PF573228 on the channel open probability. Values are means ± SEM for n = 16–18 cells in each group. *Signiﬁcantly different from control (P < 0.05)
and #signiﬁcantly (P < 0.05) different from Iban (30 M)  alone. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of
this  article.)
1186 S.-N. Wu et al. / Toxicology Reports 2 (2015) 1182–1193
Fig. 3. Effect of Iban on BKCa-channel activity at different potentials in MDCK cells.
For this purpose, cells were exposed to high-K+ solution containing 1.8 mM CaCl2
and held at different levels of membrane potentials. (A) The I–V relationships of BKCa
channels obtained in the absence () and presence () of 10 M Iban. Values are
means ± SEM for n = 15–18 cells in each point). (B) The relationships between nor-
malized channel activity and membrane potential obtained before and after addition
of  10 M Iban. Values are means ± SEM for n = 12–15 cells in each point. : control
(black); : in the presence of 10 M Iban (blue). (C) Iban (10 M)-induced Inhibi-
tion  of BKCa-channel activity at various concentrations of internal Ca2+. In this set of
experiments, inside-out current recordings were performed and different concen-
trations (0.01, 0.1 and 1 M) of Ca2+ in the bath before (blue bars) and after 10 M
Iban (red bars) were applied to the bath. Values are means ± SEM for 6–8 cells in
e *
r
t
f
c
t
i
h
Fig. 1. Effect of Iban on IK recorded from MDCK cells. (A) Original current traces
obtained with or without addition of Iban at −50 mV and a long ramp pulse
from−100 to +60 mV with a duration of 1 s at a rate of 0.05 Hz. a: control (black);
b:  10 M Iban (blue); c: 30 M Iban (red). (B) Summary of the data showing effects
of  Iban, paxilline, ketamine and Iban plus NaHS on the IK amplitude measured at
the  level of +40 mV.  Values are means ± SEM for n = 15–18 cells for each group.
Iban: 30 M Iban; Pax: 1 M paxilline; Ketamine: 100 M ketamine; NaHS:
100 M sodium hydrosulﬁde. *Signiﬁcantly different from control (P < 0.05) and
#signiﬁcantly (P < 0.05) different from Iban (30 M)  alone. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web versionach group. Signiﬁcantly different from controls (P < 0.05). (For interpretation of the
eferences to color in this ﬁgure legend, the reader is referred to the web version of
his  article.)
urther addition of soldium hydrosulﬁde (NaHS, 100 M)  signiﬁ-
antly reversed Iban-induced reduction of IK amplitude elicited by
he ramp pulse (Fig. 1B). Paxilline or ketamine are recognized as
nhibitors of BKCa channels [11,43], while NaHS which can release
ydrogen sulﬁde (H2S) was  reported to activate the activity of BKCaof  this article.)
channels [5]. Chlorotoxin (1 M),  a blocker of chloride channels,
exerted no effects on IK in these cells. The observed effect of Iban on
macroscopic IK did not appear to involve in the suppression of Cl−
channels. As such, the results suggest that Iban has a suppressive
effect on IK in these cells.
3.2. Iban suppressed BKCa-channel activity measured from MDCK
cells
A considerable mix  of different K+ channels could be measured
during whole-cell recordings. For this reason, in order to determine
how Iban can interact with ion channels to depress IK amplitude,
single-channel current recordings were performed. In this set of
experiments, cell-attached conﬁguration was  made and cells were
bathed in high K+ solution containing 1.8 mM CaCl2. As shown
in Fig. 2, under our experimental conditions, the activity of BKCa
channels can be readily detected, as described previously in dif-
ferent types of cells [5,24,41]. As Iban at a concentration of 10
or 30 M was  applied to the bath, channel activity was progres-
sively diminished (Fig. 2). For example, addition of Iban (10 M)
signiﬁcantly reduced the probability of BKCa-channel openings by
50.1 ± 2.1% from 0.178 ± 0.030 to 0.089 ± 0.015 (n = 18, P < 0.05).
Similar to the effect of Iban, paxilline (1 M)  or ketamine (10 M)
applied to the bath was effective at suppressing channel activity.
Moreover, in continued presence of 30 M Iban, further addition
of NaHS (100 M)  or PF573228 (10 M)  reversed Iban-mediated
y Reports 2 (2015) 1182–1193 1187
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Fig. 4. Effect of Iban on the kinetic properties of BKCa channels in MDCK cells. (A)
Mean open-time histograms of BKCa channels in the absence (left) and presence
(right) of 10 M Iban. Cells were bathed in high K+ solution containing 1.8 mM CaCl2
and cell-attached current recordings was made with a holding potential of +50 mV.
The abscissa and ordinate shown in each histogram respectively indicate the loga-
rithm of open time (ms) and the square root of the event number. The gray dashed
lines shown in each lifetime distribution are placed at the values of time constant
(i.e.,  fast and slow components) in the open state, and the red smooth curves were
well ﬁtted by a two-exponential function. Data in the control were obtained from
a  measurement of 431 channel openings with a total record time of 30 s, whereas
those during exposure to Iban (10 M)  were obtained from 480 channel openings
with a total record time of 1 m. In (B), the kinetics of Iban-induced reduction in the
slow component of mean open time of BKCa channels was determined. The reciprocal
of  time constant (1/b) was derived and plotted against the Iban concentration. Data
points were ﬁtted by a linear regression, indicating that Iban-mediated reduction of
mean open time occurs with a molecularity of 1. Blocking (k+1) and unblocking (k−1)
rate constants derived from different Iban concentrations were 0.00153 ms−1 M−1S.-N. Wu et al. / Toxicolog
nhibition of BKCa channels as evidenced by a signiﬁcant increase in
hannel activity to 0.097 ± 0.018 (n = 16, P < 0.05) or 0.103 ± 0.019
n = 16, P < 0.05), respectively. PF573228 was previously reported
o activate BKCa channels [37]. These results indicate that Iban can
uppress BKCa-channel activity in a concentration-dependent man-
er in MDCK cells.
.3. Inability of Iban to alter single-channel conductance
The next set of experiments was conducted to determine Iban
ffects on BKCa-channel activity measured at different voltages.
ells were bathed in high-K+ solution, which contained 1.8 mM
aCl2 and the recording pipette was ﬁlled with K+-containing
olution. The activity of BKCa channels was readily detected at dif-
erent levels of membrane potential. As expected, when membrane
ecame depolarized, the channel open probability continued to
ncrease [43]. As shown in Fig. 3A, according to an ohmic I–V rela-
ion of BKCa channels, no notable difference in the single-channel
onductance of these channels recorded from MDCK cells was
emonstrated (198 ± 12 pS [control] versus 196 ± 11 pS [10 M
ban], n = 15, P > 0.05), despite a considerable suppression of BKCa-
hannel activity during exposure to Iban. It is thus clear from these
esults that Iban did not have any effects on single-channel con-
uctance of these channels.
.4. Iban-induced shift in the activation curve of BKCa channels
Another set of experiments was further performed to examine
hether there is voltage dependence for the inhibitory effect of
ban on BKCa-channel activity. Fig. 3B shows the activation curve
f BKCa channels obtained with or without addition of 10 M Iban.
he relationships between the membrane potentials and the proba-
ility of BKCa-channel openings were derived and thereafter ﬁtted
o a Boltzmann function described in Materials and Methods. In
ontrol, V1/2 = 43.1 ± 1.9 mV  and q = 7.1 ± 0.2 e (n = 15), whereas in
he presence of 10 M Iban, V1/2 = 65.2 ± 2.2 mV  and q = 7.3 ± 0.2 e
n = 12); therefore, addition of Iban not only produced a decrease
n the maximal open probability of BKCa channels, but also signiﬁ-
antly shifted the activation curve to a positive membrane potential
y approximately 22 mV.  In contrast, there was no signiﬁcant dif-
erence in the gating charge of the activation curve between the
bsence and presence of Iban. These data indicate that, in addition
o the reduction of BKCa-channel activity, Iban is able to produce a
ightward shift in the activation curve of BKCa channels in MDCK
ells.
.5. Change in the magnitude of Iban-mediated reduction of
KCa-channel activity in different level of internal Ca2+
It was also determined whether Iban can modify the Ca2+ sensi-
ivity of BKCa channels. In this set of experiments, inside-out current
ecordings were made and different concentrations of Ca2+ in the
ath before and after addition of Iban (10 M)  to an intracellular
urface of the excised patch was applied. At a given concentration
f Iban (10 M),  the magnitude of its reduction in BKCa-channel
ctivity became notably decreased as internal Ca2+ was elevated
Fig. 3C). For example, at the holding potential of +50 mV,  Iban
10 M)  reduced the activity of BKCa channels at internal Ca2+ con-
entration of 0.1 M by 50%, while it at the same concentration
ecreased channel activity at internal Ca2+ concentration of 1 M
nly by 30%. Therefore, these data indicated that the presence of
ban was able to alter Ca2+ sensitivity of BKCa channels in MDCK
ells.and 0.0187 ms−1, respectively. Each point represent the mean ± SEM (n = 9–12). (For
interpretation of the references to color in this ﬁgure legend, the reader is referred
to  the web  version of this article.)
3.6. Evaluation of Iban-induced decrease in the slow component
of mean open time of BKCa channels in MDCK cells
Since Iban-induced decrease of BKCa-channel activity tends to
arise notably from a reduction in channel open probability rather
than the decreased number of active channels, effects of Iban on
the kinetic behavior of BKCa channels were further analyzed. As
shown in Fig. 4A, in cell-attached patches of control cells (i.e.,
in the absence of Iban), the distribution of open-time durations
of BKCa channels measured at the level of +50 mV was convinc-
ingly ﬁt by a two-exponential equations with a mean open time of
2.3 ± 0.1 and 45.6 ± 5.6 msec (n = 12). Particularly, during exposure
to 10 M Iban, the mean duration of the slow components of open-
time distribution was  drastically shortened. For example, Iban at
a concentration of 10 M signiﬁcantly decreased the slow compo-
nent of mean open time to 21.5 ± 2.5 ms  (n = 12, P < 0.05), while no
signiﬁcant change in the fast component of mean open time was
1188 S.-N. Wu et al. / Toxicology Reports 2 (2015) 1182–1193
Fig. 5. Effect of membrane stretch on Iban-mediated inhibition of BKCa-channel activity in MDCK cells. Cells were bathed in high K+ solution containing 1.8 mM CaCl2. The
experiments were conducted in cell-attached conﬁguration with a holding potential of +30 mV.  (A) Original current traces showing Iban-induced reduction of BKCa-channel
activity  obtained before (upper, black) and after (lower, blue) the membrane stretch induced by a negative pressure (−2 and −4 kPa). Upward deﬂections are the opening
events  of the channels. (B) Bar graph showing effects of negative pressure(−2 and −4 kPa) on BKCa channels in the absence (blue bars) and presence of 10 M Iban (red bars).
Values  are means ± SEM for n = 7–10 cells in each group. *Signiﬁcantly different from controls (P < 0.05). (For interpretation of the references to color in this ﬁgure legend,
the  reader is referred to the web  version of this article.)
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een (2.2 ± 0.2 ms  [n = 12], P > 0.05). The data can be interpreted to
ean that Iban-mediated reduction of BKCa channels is primarily
ttributable to the shortening of mean open time, despite the fact
hat it fails to modify single-channel conductance of these channels.
During exposure to Iban, in addition to the decreased probabil-
ty of BKCa-channel openings, the slow component of mean open
ime for BKCa channels became shortened. To provide more evi-
ence for Iban-induced reduction of BKCa-channel activity, the time
onstants for the slow component of mean open time obtain in
ifferent Iban concentrations were quantitatively analyzed in this
tudy. Interestingly, the effect of Iban on BKCa channels in MDCK
ells were found to result in a concentration-dependent shortening
n the slow component of mean open time (Fig. 4B). According to the
rst-order blocking scheme described in Materials and Methods,
he relationship between 1/b and [B] became linear with corre-
ation coefﬁcient of 0.96 (Fig. 4B). The resultant rate constants of
locking and unblocking perturbed by the presence of Iban were
.00153 ms−1M−1 and 0.0187 ms−1, respectively. Dividing k−1 by
+1 is equal to 12.2 M,  a value for the dissociation constant (KD).
.7. Effect of membrane stretch on Iban-mediated reduction of
KCa-channel activity
It has been demonstrated that ﬂuid ﬂow or shear force may
lter the activity of BKCa channels or [Ca2+]i in renal tubular cells
13,17,31]. Previous reports have shown the ability of membrane
tretch to enhance BKCa-channel activity [5,36,43,44]. We  next
etermined whether Iban effects on these cells can be altered dur-
ng different level of membrane stretch. It is noted that as an abrupt
uction (−2 or −4 kPa) was applied to the membrane, the prob-
bility of BKCa-channel openings became raised (Fig. 5). As such,
n MDCK cells, application of membrane stretch can enhance the
ctivity of BKCa channels, although this maneuver actually did not
odify single-channel conductance. Findings from these results
hus led us to suggest that the BKCa channel may  in part account for
tretch- or ﬂow-induced cellular effects in renal tubular cells in vivo
31]. As shown in Fig. 5, addition of Iban was found to reduce the
robability of BKCa channels taken in these cells. However, the mag-
itude of Iban-mediated inhibition of BKCa-channel activity did not
iffer signiﬁcantly in membrane stretch created with −2, −4 and
6 kPa (Fig. 5B).
.8. Effect of Iban and oxalate on the activity of BKCa channels
Oxalate was previously reported to interact with Ca2+ in renal
ubular cells, and nitrogen-containing bisphosphonates could pre-
ent the formation of calcium oxalate stone [1,7,26,34]. As such,
e intended to explore whether the inhibitory effects of Iban and
xalate on these channels can operate to be additive. Of interest,
s shown in Fig. 6, Iban (10 M)  produced a reduction of the chan-
el open probability measured at the level of +50 mV;  however,
 subsequent addition of oxalate (30 M)  did not decrease chan-
el activity further. Oxalate (30 M)  alone signiﬁcantly reduced
he probability of BKCa-channel openings from 0.192 ± 0.015 to
.082 ± 0.008 (n = 12, P < 0.05). There was no signiﬁcant difference
n the channel open probability between the presence of Iban alone
nd Iban plus oxalate (0.084 ± 0.009 [n = 13] versus 0.082 ± 0.012
n = 11], P > 0.05). These results thus indicate that the inhibition
ction by Iban and oxalate of single BKCa channels in MDCK cells is
ot additive.rts 2 (2015) 1182–1193 1189
3.9. Inhibitory effect of Iban, TRAM-34, Iban plus DC-EBIO and
Iban plus 9-phenanthrol (9-PA) on the activity of
intermediate-conductance Ca2+-activated K+ (IKCa) channels in
MDCK cells
Earlier work in our laboratory has shown the inhibitory effects
of Iban on IKCa-channel activity in RAW 264.7 osteoclast precur-
sor cells [45]. In another set of experiments, we  further assessed
whether the activity of IKCa channels in MDCK cells can be sensitive
to any change in the presence of Iban. As shown in Fig. 7, during cell
exposure to Iban at a concentration of 30 and 100 M, the probabil-
ity of IKCa-channel openings were drastically decreased, although
this compound was unable to modify single-channel amplitude.
Similarly, TRAM-34 (3 M),  an inhibitor of IKCa channels, was  effec-
tive at suppressing the activity of IKCa channels. Iban-induced
reduction of IKCa channels was reversed by further addition of
either DC-EBIO or 9-phenanthrol. Both DC-EBIO and 9-phenanthrol
were reported to activate IKCa channels [8,35,45]. Therefore, the
present results showing the Iban’s ability to suppress IKCa-channel
activities are consistent with our previous report made in RAW
264.7 cells [45].
3.10. Effect of Iban, Iban plus PF573228, and Iban plus DC-EBIO
on membrane potential in MDCK cells
To determine whether Iban has any effects on the membrane
potential of MDCK cells, a ﬁnal set of experiments were con-
ducted under current-clamp recordings. Cells, bathed in normal
Tyrode’s solution containing 1.8 mM CaCl2, had a resting poten-
tial of −58.4 ± 2.6 mV  (n = 19). When MDCK cells were exposed
to Iban (30 M),  the membrane potential became progressively
depolarized to −52.1 ± 2.8 mV  (n = 13, P < 0.05) (Fig. 8). Subsequent
application of PF573228 (10 M)  reversed Iban-mediated depo-
larization as evidenced by membrane hyperpolarization back to
−56.1 ± 2.4 mV  (n = 12, P < 0.05). Similarly, in continued presence
of Iban (30 M),  a further addition of DC-EBIO hyperpolarized the
cells back to −56.3 ± 2.6 mV  (n = 11, P < 0.05). The typical effects
of Iban, Iban plus PF573228 and Iban plus DC-EBIO on changes in
membrane potential in MDCK cells are illustrated in Fig. 8A. These
results reﬂect that Iban-mediated membrane depolarization seen
in MDCK cells can result primarily from its inhibition of BKCa or/and
IKCa channels. The inhibitory action on the activity of both BKCa and
IKCa channels may  cause membrane depolarization, thereby affect-
ing functional activities of renal tubular cells, if this action occurring
in native cells is the same as that shown here.
4. Discussion
In this study, the single-channel conductance of BKCa channels
measured with the use of 145 mM K+ on both sides of the mem-
brane in MDCK was  198 ± 12 pS (n = 15). This value is similar to
those of typical BKCa channels described previously in different cell
types [5,11], but much greater than those of small- or intermediate-
conductance Ca2+-activated K+ channels. Moreover, the channel
activity presented here is sensitive to stimulation by membrane
depolarization, [Ca2+]i and membrane stretch, and it can be blocked
by paxilline or ketamine.
A previous study showed that H2S donor could prevent gas-
tric damage caused by alendronate, another bisphosphonate [25].
Consistent with previous studies [5], our results demonstrated the
ability of NaHS/H2S to counteract Iban-mediated decrease of both
macroscopic IK amplitude and BKca-channel activity recorded from
MDCK cells. H2S has been reported to protect the kidney against
different forms of injury [16]. Therefore, this volatile molecule
1190 S.-N. Wu et al. / Toxicology Reports 2 (2015) 1182–1193
Fig. 6. Inhibitory effects of Iban and oxalate on the activity of BKCa channels recorded from MDCK cells. The experiments were conducted in symmetrical K+ solution (145 mM)
containing 1.8 mM CaCl2, and the channels were recorded from cell-attached patched of MDCK cells. The potential was held at +50 mV. (A) Original current traces obtained in
control  (black) or during the exposure to 10 M Iban (blue), 30 M oxalate (red), or 10 M Iban plus 30 M oxalate (green). (B) Bar graph showing the effect of Iban (10 M)
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as  subsequently applied after addition of Iban to the bath. *Signiﬁcantly different 
he  reader is referred to the web  version of this article.)
ay  protect the damage by bisphosphonates of renal epithelium
hrough a mechanism linked to activation of BKCa channels.
Numerous reports have demonstrated that ketamine, a recre-
tional drug owing to its anesthetic and hallucinogenic actions,
ould produce signiﬁcant nephrotoxicity [4,6,12,33,39]. In this
tudy, this agent was noted to suppress IK amplitude, and
ts effect could ascribe from its suppression of BKCa channels
s reported previously [11]. Whether ketamine-induced tubu-
ar cell necrosis or obstructive uropathy described previously
4,6,12,33,39] is associated with an inhibition of BKCa channels
emain to be further studied. Moreover, the administration of bis-
hosphonates would potentially exacerbate ketamine-mediated
amage, because both agents suppress the activity of BKCa
hannels in renal tubular cells or smooth muscle cells of a for n = 11–13 cells in each group. In the experiments with Iban plus oxalate, oxalate
ontrol (P < 0.05). (For interpretation of the references to color in this ﬁgure legend,
urinary bladder. Meanwhile, in continued presence of Iban,
oxalate-induced inhibition of BKCa channels seen in MDCK
was abolished, suggesting that these two  agents may  work
through a similar mechanism. Our results are in agreement
with a number of studies reporting that bisphosphonates have
a preventive role in the formation of calcium oxalate stones
[1,7,26,30,34].
In the present study, the ability of Iban to produce an appar-
ent shift of 22 mV  to a positive potential in the activation curve of
BKCa channels in MDCK cells was  observed without any changes in
the gating charge of this curve for the opening of BKCa channels.
It is thus possible that its interaction with BKCa channels is not
mediated through a direct effect on voltage sensor per se.  Unlike its
effects on IKCa channels [45], the binding site of Iban is most likely
S.-N. Wu et al. / Toxicology Reports 2 (2015) 1182–1193 1191
Fig. 7. Effects of Iban on the activity of IKCa channels recorded from MDCK cells. In these experiments, cells were immersed in normal Tyrode’s solution containing 1.8 mM
CaCl2, and the holding potential was set at 0 mV  relative to the bath when the recording pipette with ﬁlled with K+-containing solution. (A) Original traces of IKCa channels
obtained in control (upper, black) and after addition of 100 M Iban (lower, blue). Notably, unlike the activity of BKCa channels described above, downward deﬂection indicates
t an, TR
c group
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ihe  opening event of the IKCa channel. (B) Summary of the data showing effects of Ib
hannel  openings in MDCK cells. Values are means ± SEM for n = 10–13 cells in each 
rom  Iban (100 M)  alone. 9-PA: 9-phenanthrol. (For interpretation of the reference
o lie outside of the trans-membrane ﬁeld. Our results also clearly
howed that in MDCK cells, membrane stretch could enhance the
ctivity of BKCa channels, despite inability of this maneuver to
lter the single-channel conductance of these channels during such
aneuver. The BKCa channel in MDCK cells thus indeed exhibits a
echano-sensitive property as described previously [5,36,44,46].
hese data suggest that the BKCa channel may  play a role in stretch-
 volume- or ﬂow-dependent cellular effects in renal tubular cells
n vivo [17,31]. Iban could decrease the probability of BKCa-channel
penings in MDCK cells as well as modify the Ca2+ sensitivity of
KCa channels. The results reﬂect that this compound can exert
ts effect via a decrease in the afﬁnity of Ca2+ ions for Ca2+ bind-
ng site in the membrane. Therefore, during an increase in tensileAM-34, Iban plus DC-EBIO, and Iban plus 9-phenanthrol on the probability of IKCa-
. *Signiﬁcantly different from control (P < 0.05) and #signiﬁcantly (P < 0.05) different
olor in this ﬁgure legend, the reader is referred to the web version of this article.)
strength of renal tubule, membrane depolarization, changes in rest-
ing [Ca2+]i, and membrane stretch may  synergistically contribute to
the opening of BKCa channels enriched in renal tubular cells, which
are sensitive to inhibition by Iban or other bisphosphonates.
On the basis of a minimal reaction scheme, the KD value of Iban
required for Iban-induced shortening in the slow component of
mean open time measured from BKCa channels is 12.2 M.  This
value is lower than that used to suppress the activity of IKCa channel
in RAW 264.7 cells [45]. Both decreased IK amplitude and mem-
brane depolarization caused by this agent in renal tubular cells can
be dependent not only on the Iban concentration, but also on the
pre-existing membrane potential, [Ca2+]i, and membrane stretch.
The estimated peak of plasma Iban concentration has been reported
1192 S.-N. Wu et al. / Toxicology Reports 2 (2015) 1182–1193
Fig. 8. Effects of Iban, Iban plus PF573228 and Iban plus DC-EBIO on membrane potential in MDCK cells. In current-clamp conﬁguration, cells were bathed in normal Tyrode’s
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Dolution  containing 1.8 mM CaCl2. (Aa) Original potential trace showing effects of Ib
howing  effect of Iban (30 M)  and DC-EBIO (10 M)  on membrane potential. (B) S
n  membrane potential of MDCK cells. Values are means ± SEM for n = 11–15 cells 
ifferent from Iban (30 M)  alone.
o reach 5 × 103 ng/ml (around 14 M)  [21]. Additionally, the bis-
hosphonates like Iban can be virtually taken or even accumulated
n renal tubular cells through the process of ﬂuid phase endocytosis
3,38]. Consequently, the observed effects by Iban on BKCa channels
end to develop during the open state of the channel and may  occur
t the range of the concentrations achievable in humans.
In this study, we were unable to detect voltage-gated Na+ or Ca2+
urrents in MDCK cells. Distinguished from previous reports made
n thyroid and breast cancer cells and [20,48], addition of Iban at
 concentration of 10 M did not produce any change in the level
f [Ca2+]i in MDCK cells, nor did it enhance BKCa-channel activity.
o clear difference in acute nephrotoxicity caused by zolendronate
nd Iban was reported [18]. Iban at higher concentrations also vir-
ually suppressed the activity of IKCa channels in MDCK cells, and
C-EBIO or 9-phenanthrol counteracted Iban-induced suppression M)  and PF573228 (10 M)  on membrane potential. (Ab) Original potential trace
ary of the data showing effect of Iban, Iban plus PF573228, and Iban plus DC-EBIO
h group. *Signiﬁcantly different from control (P < 0.05) and #signiﬁcantly (P < 0.05)
of these channels. Therefore, it seems unlikely that Iban-mediated
inhibition of BKCa- or IKCa-channel activity in renal tubular cells
results predominantly from sustained elevation of [Ca2+]i.
In renal epithelial cells, K+ recycling is an essential step in the
control of trans-epithelial transport. Any activation of KCa chan-
nels would enhance K+ recycling, hyperpolarize the membrane
potential, and facilitate the transport of other ions (e.g., Na+ and
Ca2+ ions) or solutes [24,40,41,44]. In addition to inhibition of far-
nesyl pyrophosphate synthase [19], the inhibitory effects of Iban
on these channels may  signiﬁcantly contribute to the underlying
mechanisms by which it and other structurally related bisphospho-
nates affect functional activities of renal epithelial cells, assuming
that similar ﬁndings can occur in vivo. Whether the nephrotoxicity
caused by chronic treatment with Iban occurring in vivo is linked to
its effects on ion-channel activity needs to be further investigated.
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